ReviewJournal of experimental & clinical cancer research : CR2025

Tfcp2l1 as a central integrator of hypoxia, dedifferentiation, and tumor progression.

Cynthia Clemente-González et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.